{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:54:22Z","timestamp":1785218062151,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Because prostate-specific membrane antigen (PSMA) expression is universal in juvenile nasal angiofibroma (JNA), PSMA PET\/CT is commonly used in the postoperative setting using the postoperative angiofibroma radionuclide imaging study protocol. Our study aims to illustrate physiological PSMA ligand uptake distribution characteristics in the salivary glands, specifically the tubarial glands with tumor, to aid in accurate PSMA PET\/CT analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Design<\/jats:title>\n            <jats:p>Forty-three consecutive patients who underwent a dedicated head and neck spot PSMA PET\/CT for JNA were evaluated retrospectively. PSMA SUV<jats:sub>max<\/jats:sub> values in the tumor, tubarial, parotid, submandibular, and sublingual salivary glands were determined visually and quantitatively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All the tumors and the salivary glands showed increased tracer uptake. The median SUV<jats:sub>max<\/jats:sub> \u00b1 SD ratios of the tumor, right and left tubarial gland, right and left parotid gland, right and left submandibular gland, and right and left sublingual gland were 2.7 \u00b1 0.8 (range, 0.5\u20137.5), 3.8 \u00b1 1.9 (range, 0.9\u20138.1), 4.7 \u00b1 2.1 (range, 0.8\u20137.4), 9.5 \u00b1 4.8 (range, 3.2\u201321.9), 9.2 \u00b1 4.7 (range, 2.9\u201318.9), 10.4 \u00b1 5.7 (range, 3.5\u201325.4), 10.4 \u00b1 5.5 (range, 3.7\u201326.4), 6 \u00b1 4.1 (range, 1.3\u201320.6), and 6.5 \u00b1 4.2 (range, 1.8\u201319.7), respectively. The uptake in the tubarial glands was comparable with that of the tumor but less compared with other major salivary glands.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Ours is the first study demonstrating the quantitative uptake of tubarial salivary glands in detail. Because the tubarial glands uptake and the anatomical location are similar to that of the tumor, these physiological uptakes must be borne in mind to circumvent false-positive interpretations and care must be given during the planning of stereotactic radiotherapy for JNAs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003583","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:03:17Z","timestamp":1617076997000},"page":"e398-e405","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Physiological PSMA Uptake in the Tubarial Salivary Glands and Its Implications in the PARIS Protocol\u2014A First Study of Its Kind!"],"prefix":"10.1097","volume":"46","author":[{"given":"Pirabu","family":"Sakthivel","sequence":"first","affiliation":[{"name":"Otorhinolaryngology and Head and Neck Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Thakar","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology and Head and Neck Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreedharan Thankarajan","family":"Arunraj","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Prashanth","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology and Head and Neck Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Chandra","family":"Sharma","sequence":"additional","affiliation":[{"name":"Otorhinolaryngology and Head and Neck Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00259-017-3922-y","article-title":"Targeting PSMA by radioligands in non-prostate disease\u2014current status and future perspectives","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/RLU.0000000000002928","article-title":"Prostate-specific membrane antigen expression in primary juvenile nasal angiofibroma\u2014a pilot study","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/RLU.0000000000002387","article-title":"Juvenile nasal angiofibroma on 68Ga-PSMA PET\/CT: opening new frontiers","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/RLU.0000000000002745","article-title":"Clinical utility of 68Ga-prostate-specific membrane antigen PET\/CT scan on postoperative assessment of juvenile nasal angiofibroma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/RLU.0000000000002951","article-title":"Comparison of 68Ga-PSMA PET\/CT and contrast-enhanced MRI on residual disease assessment of juvenile nasal angiofibroma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13139-019-00628-4","article-title":"Clinical applications of 68Ga-PSMA PET\/CT on residual disease assessment of juvenile nasopharyngeal angiofibroma (JNA)","volume":"54","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1097\/RLU.0000000000003041","article-title":"Fusion 68Ga-prostate-specific membrane antigen PET\/MRI on postoperative surveillance of juvenile nasal angiofibroma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1097\/RLU.0000000000003311","article-title":"Comparison of prostate-specific membrane antigen PET\/CT and contrast-enhanced magnetic resonance imaging in follow-up assessment of juvenile nasal angiofibroma\u2014a novel pilot study","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1097\/RLU.0000000000003359","article-title":"Advantage of 68Ga-PSMA PET\/CT on postradiotherapy response assessment of juvenile nasal angiofibroma","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","article-title":"Validation of postoperative angiofibroma radionuclide imaging study (PARIS) protocol using PSMA PET\/CT\u2014a proof of concept study","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","article-title":"Clinical utility of Ga68 DOTANOC PET\/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report","year":"2021","journal-title":"Nucl Med Commun"},{"key":"bib12-20250621","article-title":"The tubarial salivary glands: a potential new organ at risk for radiotherapy","year":"2020","journal-title":"Radiother Oncol"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/1078-1439(95)00002-Y","article-title":"Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues","volume":"1","year":"1995","journal-title":"Urol Oncol"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/pros.21090","article-title":"Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer","volume":"70","year":"2010","journal-title":"Prostate"},{"key":"bib15-20250621","first-page":"3192","article-title":"Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated Neovasculature","volume":"59","year":"1999","journal-title":"Cancer Res"},{"key":"bib16-20250621","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","year":"1997","journal-title":"Clin Cancer Res"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nucmedbio.2016.05.006","article-title":"Preparation of [(68)Ga]PSMA-11 for PET-CT imaging using a manual synthesis module and organic matrix based (68)Ge\/(68)Ga generator","volume":"43","year":"2016","journal-title":"Nucl Med Biol"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40644-016-0095-z","article-title":"Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal metastases","volume":"16","year":"2016","journal-title":"Cancer Imaging"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1097\/RLU.0000000000001672","article-title":"Evaluation of practical interpretation hurdles in 68Ga-PSMA PET\/CT in 55 patients: physiological tracer distribution and incidental tracer uptake","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","article-title":"Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET\/CT imaging","volume":"37","year":"2016","journal-title":"Nucl Med Commun"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.oooo.2018.01.011","article-title":"Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET\/CT","volume":"125","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s003300050468","article-title":"Postoperative follow-up of juvenile nasopharyngeal angiofibromas: assessment by CT scan and MR imaging","volume":"8","year":"1998","journal-title":"Eur Radiol"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hed.21667","article-title":"Adjuvant therapy with flutamide for presurgical volume reduction in juvenile nasopharyngeal angiofibroma","volume":"33","year":"2011","journal-title":"Head Neck"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.amjoto.2018.11.010","article-title":"The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites","volume":"40","year":"2019","journal-title":"Am J Otolaryngol"},{"key":"bib26-20250621","article-title":"Clinical implications of tubarial salivary glands","year":"2020","journal-title":"Radiother Oncol"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"298","DOI":"10.14219\/jada.archive.1989.0211","article-title":"The role of saliva in maintaining oral homeostasis","volume":"119","year":"1989","journal-title":"J Am Dent Assoc"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0003-9969(99)90002-X","article-title":"Morphological features of the minor salivary glands","volume":"44","year":"1999","journal-title":"Arch Oral Biol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:22Z","timestamp":1750539802000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003583","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,30]]}}}